Product Information

LITHIUM 8 MEQ/5 ML SOLUTION is a generic product labeled by Advagen Pharma Ltd., priced at $0.4694 per ML under NDC 72888017246. Its NADAC has been published 53 times since Aug 20, 2025.

FDA first approved this application on Aug 14, 2023. Its Orange Book therapeutic-equivalence code is AA.

LITHIUM 8 MEQ/5 ML SOLUTION

Lithium
$0.4694per ML

Strength

8 meq/5mL

NDC

72888017246

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LITHIUM CITRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA218036

FDA Approved

8/14/2023

TE Code

AA

On Market Since

11/9/2022

Pharmacological Classes

Price Statistics

The NADAC for LITHIUM 8 MEQ/5 ML SOLUTION has been published 53 times since Aug 20, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.4694 per ML
All-time high$0.4808 (May 13, 2026)
All-time low$0.4694 (Aug 19, 2026)
52-week high$0.4808
52-week low$0.4694
Median price$0.4758
Average price$0.4761
Largest weekly change-1.3% (Aug 19, 2026)
Weeks tracked53
Tracking sinceAug 20, 2025

Price History

1W

-1.3%

1M

-1.3%

3M

-1.5%

6M

-2.4%

1Y

-0.1%

3Y

N/A

5Y

N/A

All

-0.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lithium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of LITHIUM 8 MEQ/5 ML SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for LITHIUM 8 MEQ/5 ML SOLUTION, manufactured by Advagen Pharma Ltd., is $0.4694 per ML (NDC 72888017246), effective Aug 19, 2026.

How has the price of LITHIUM 8 MEQ/5 ML SOLUTION changed over time?

Over the history we have for it, the NADAC for LITHIUM 8 MEQ/5 ML SOLUTION has held within roughly two percent of its current level. It has been tracked across 53 weekly CMS publications since Aug 20, 2025.

What are the highest and lowest recorded NADAC prices for LITHIUM 8 MEQ/5 ML SOLUTION?

Since Aug 20, 2025, the NADAC for LITHIUM 8 MEQ/5 ML SOLUTION has ranged from a low of $0.4694 (Aug 19, 2026) to a high of $0.4808 (May 13, 2026), with a median of $0.4758 per ML.

Are there cheaper alternatives to LITHIUM 8 MEQ/5 ML SOLUTION?

No other NADAC-published product currently shares the active ingredient and strength of LITHIUM 8 MEQ/5 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LITHIUM 8 MEQ/5 ML SOLUTION?

LITHIUM 8 MEQ/5 ML SOLUTION (NDC 72888017246) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.